# Ring Therapeutics, INC. 401(k) Plan
Source: https://planprovider.pro/companies/ring-therapeutics-inc-401k-plan

> Ring Therapeutics, INC.&#39;s 401(k) plan: 52 participants, plan year 2024 financials, providers, and benchmarks from Form 5500.

Form 5500 filing data for plan year 2024.

## Plan Snapshot

- **Plan Sponsor:** Ring Therapeutics, INC.

- **Sponsor EIN:** 821651880

- **Sponsor Address:** 140 FIRST STREET, SUITE 401, CAMBRIDGE, MA, 02141

- **Plan Type:** 401(k)

- **Total Participants:** 52

- **Total Assets:** $4.3M

## Key Plan Design Features

- **Auto-Enrollment:** Yes

- **Auto-Escalation:** No

- **Allows Roth Contributions:** Yes

- **Participant Loans:** No

- **Participant-Directed Investments:** Yes

- **ERISA Section 404(c) Fiduciary Safe Harbor:** Yes

## Plan Financials by Year

| Year|Participants|Total Assets|Employer Contrib.|Employee Contrib.|

| 2024|52|$4.3M|$1,491|$1.2M|

| 2023|106|$3.2M|$5,043|$1.2M|

| 2022|144|$1.8M|$0|$1.3M|

## Service Providers (Schedule C)

Vendors paid $5,000 or more for services to the plan, ranked by total compensation (direct + indirect fees).

| Provider Name|
Role|
Direct Compensation|
Indirect Compensation|
Total Fees|

| GRAY, GRAY AND GRAY LLP|Auditor|—|—|$0|

## Plan Fees & Expenses

Annual service provider fees and administrative expenses sourced from DOL Form 5500 filings.

- **Total Service Provider Fees:** $0

### Historical Administrative Expenses

Breakdown of administrative expense categories reported on Form 5500 filings.

| Year|
Total Admin Expenses|
Investment Mgmt Fees|
Contract Admin Fees|
IQPA Audit Fees|
Professional Fees|

| 2024|$2,712|—|—|—|—|

| 2023|$770|—|—|—|—|

| 2022|—|—|—|—|—|

## Similar Plans

- [Tiax LLC](https://planprovider.pro/companies/tiax-llc-401k-plan) — 54 participants

- [Fulcrum Therapeutics, INC.](https://planprovider.pro/companies/fulcrum-therapeutics-inc-401k-plan) — 49 participants

- [Geosearch, INC.](https://planprovider.pro/companies/geosearch-inc-401k-plan) — 49 participants

- [Amryt Pharmaceuticals, INC.](https://planprovider.pro/companies/amryt-pharmaceuticals-inc-401k-plan) — 55 participants

- [Codiak Biosciences, INC.](https://planprovider.pro/companies/codiak-biosciences-inc-401k-plan) — 48 participants

- [Repertoire Immune Medicines, INC](https://planprovider.pro/companies/repertoire-immune-medicines-inc-401k-plan) — 56 participants

[View full interactive plan profile on PlanProvider.Pro](https://planprovider.pro/companies/ring-therapeutics-inc-401k-plan)

&copy; 2026 PlanProvider.Pro
